Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

<< Back to News

2/14/22 js Clarification of Entresto-valsartan event
February 16, 2022

From: "Jill Shelton" <jill.shelton@hhsys.org>
To: "Pharmacists" <grp_allpharm@hhsys.org>
Sent: Monday, February 14, 2022 1:43:05 PM
Subject: Clarification  of Entresto-valsartan event

The pharmacy related error (Entresto-valsartan) emailed last Friday needs some clarification.

The alert that fired for the MD and pharmacist was actually the duplicate medication alert. The ACE-I/Entresto 36 hour alert will only trigger when verifying Entresto. When verifying an ARB or ACE-I for a patient already on Entresto a duplicate alert will pop-up. The 36 hour timeframe was not the issue in this event. However, the MD should have been contacted about the duplicate alert and not over-ridden. Sorry for the confusion.


--






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved